UCLA Hematology/Oncology- Irvine — Irvine, California

UCLA Hematology/Oncology- Irvine is a clinical research site located in Irvine, California, United States 92604.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology- Irvine has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Irvine

Browse all research sites in California · View every site in Irvine

• University of California Irvine Chao Family Comprehensive Cancer Center
• University of California Irvine /ID# 229390
• University of California Irvine /ID# 205136
• University of California, Irvine Dermatology Clinical Research Center
• University of California, Irvine - Sue & Bill Gross Stem Cell Research Center
• University of California Irvine - Gavin Herbert Eye Institute
• University of California Irvine - School of Medicine- Site Number : 8401143
• University of California Irvine Medical Center (UCIMC) - Amyotrophic Lateral Sclerosis (ALS) and Neuromuscular Center
• Department of Ophthalmology, University of California, Irvine
• The PREVENT Lab, University of California, Irvine
• Center for Functional Onco-Imaging, University of California
• Susan Samueli Integrative Health Institute, University of California, Irvine

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology- Irvine?

UCLA Hematology/Oncology- Irvine has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology- Irvine conducted?

UCLA Hematology/Oncology- Irvine has 4 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer.

Is UCLA Hematology/Oncology- Irvine accredited by Crixeo Clinical Trials?

UCLA Hematology/Oncology- Irvine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology/Oncology- Irvine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.